Close
What would you like to look for?
Site search
Search filters

Aktiia Secures USD 42m Series-B-Funding to Expand into New Markets

27 May 2025

Aktiia, a blood pressure intelligence platform, has completed an oversubscribed USD 42m Series-B funding-round, bringing the company's total funding to date to USD 100m.

HAYA Therapeutics raises USD 65m in Series-A-Funding

16 May 2025

HAYA Therapeutics AG has successfully closed its Series-A-financing round of USD 65m – an important step toward its vision of reprogramming disease-causing cellular states.

Matignon Group acquires Meon Clinic AG and Meon Center AG

13 May 2025

The Matignon Group acquires 100% of the shares of Meon Clinic AG and Meon Center AG, based in Lucerne and Meggen.

MCH Group and Bits & Pretzels establish joint venture

8 May 2025

MCH Group and Bits & Pretzels are joining forces under the joint venture health.tech events AG and launching health.tech | global summit, a new international leading conference for digital innovations in healthcare.

Granite Bio Debuts with USD 100m of Capital

5 May 2025

Granite Bio AG receives USD 100m in financing through the closing of a USD 30m Series A financing round led by founding investors Versant Ventures and Novartis Venture Fund and a USD 70m Series B financing round led by Forbion and Sanofi Ventures.

VISCHER advises sellers on the sale of Swissterminal AG to DP World Inland B.V.

28 March 2025

The majority owners of Swissterminal AG, a key player in the Swiss and French logistics markets, sold their remaining shares to the global port and logistics service provider DP World Inland B.V.

Twing Group AG sells shares to Baculus Holding AG

17 March 2025

VISCHER advised the owners of Twing Group AG in the sale of all their shares to Baculus Holding AG, a portfolio company of Nachfolgepartner AG.

VISCHER advises founders on the sale of Mibex Software GmbH to Communardo Group GmbH

28 February 2025

All shares of Mibex Software GmbH were acquired by the German Communardo Group GmbH, a portfolio company of Bregal Unternehmerkapital.

BID Equity acquires CRISALIX group

28 February 2025

BID Equity erwirbt die CRISALIX-SA, ein Schweizer Unternehmen mit Sitz in Ecublens, das sich auf die Entwicklung wissenschaftlicher, medizinischer Virtual-Reality-(VR) und 3D-Bildgebungssysteme spezialisiert hat.

IonQ acquires majority stake in id Quantique

28 February 2025

IonQ has entered into a definitive agreement with SK Telecom and id Quantique to acquire a controlling interest in id Quantique in a share-for-share transaction.